izpis_h1_title_alt

Effects of coenzyme Q$_{10}$ supplementation on oxidative stress markers, inflammatory markers, lymphocyte subpopulations, and clinical status in dogs with myxomatous mitral valve disease
ID Druzhaeva, Natalia (Avtor), ID Nemec Svete, Alenka (Avtor), ID Tavčar-Kalcher, Gabrijela (Avtor), ID Babič, Janja (Avtor), ID Ihan, Alojz (Avtor), ID Pohar, Katka (Avtor), ID Krapež, Uroš (Avtor), ID Domanjko-Petrič, Aleksandra (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (367,55 KB)
MD5: CC92FD434DADF93F2ED55C1E25C6F151
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2076-3921/11/8/1427 Povezava se odpre v novem oknu

Izvleček
Scarce data exist on the effects of coenzyme Q$_{10}$ (CoQ$_{10}$) supplementation in dogs with myxomatous mitral valve disease (MMVD). The purpose of this study was to investigate the effect of CoQ$_{10}$ supplementation on oxidative stress markers (glutathione peroxidase, F2-isoprostanes), markers of inflammation (tumor necrosis factor-α, TNF soluble receptor II, leucocytes, and their subtypes), lymphocyte subpopulations (T helper and cytotoxic T lymphocytes, including activated T lymphocytes, and B lymphocytes), and echocardiographic and clinical parameters in dogs with MMVD. In this randomized, controlled, double-blind, longitudinal study, 43 MMVD dogs in stages ACVIM (American College of Veterinary Internal Medicine classification) B2 and ACVIM C and D (congestive heart failure (CHF)) received water-soluble coenzyme Q$_{10}$ (100 mg twice daily) or placebo for 3 months, and 12 non-supplemented healthy dogs served as controls. All parameters were measured before and after supplementation in MMVD dogs and once in healthy dogs. CoQ$_{10}$ supplementation had a positive impact on neutrophil percentage, lymphocyte percentage, and lymphocyte concentration in our cohort of dogs with CHF (ACVIM C and D). Conclusion: CoQ$_{10}$ as an oral supplement may have benefits in terms of decreasing inflammation in dogs with MMVD and CHF.

Jezik:Angleški jezik
Ključne besede:coenzyme Q$_{10}$, ubiquinone, supplementation, myxomatous mitral valve disease, congestive heart failure, dog, oxidative stress, inflammation, lymphocytes, neutrophils, coenzymes, heart failure
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:VF - Veterinarska fakulteta
MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:22 str.
Številčenje:Vol. 11, iss. 8, art. 1427
PID:20.500.12556/RUL-138596 Povezava se odpre v novem oknu
UDK:636.7.09:577:616
ISSN pri članku:2076-3921
DOI:10.3390/antiox11081427 Povezava se odpre v novem oknu
COBISS.SI-ID:116770819 Povezava se odpre v novem oknu
Datum objave v RUL:02.08.2022
Število ogledov:454
Število prenosov:115
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Antioxidants
Skrajšan naslov:Antioxidants
Založnik:MDPI
ISSN:2076-3921
COBISS.SI-ID:522976025 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0053
Naslov:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj